Dudediligence.

Larimar Therapeutics, Inc

LRMRNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$15.5MSep ’24−$28.8MDec ’24−$29.3MMar ’25−$26.2MJun ’25−$47.7MSep ’25−$62.5MDec ’25−$29.6MMar ’26−$32.8MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$50.5M−$36.5M−$41.8M−$90.9M−$172.5M
Net income−$50.6M−$35.4M−$36.9M−$80.6M−$165.7M
Operating cash flow−$42.1M−$27.6M−$33.5M−$70.8M−$113.2M
Free cash flow−$42.4M−$27.7M−$33.6M−$71.3M−$113.3M
Cash$70.1M$26.8M$26.7M$33.2M$85.4M
Shares outstanding17.7M43.3M43.9M63.8M83.1M